Sandoz Sets Generics Focus As US Sale Awaits

Believes Clearance For US Divestment To Aurobindo Is Imminent

Clock
Sandoz is awaiting FTC clearance to complete the sale of its US oral-solid and dermatology operations to Aurobindo • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

More from Business